Hubei Yizhi Konjac Biotechnology920273.BJValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Hubei Yizhi Konjac Biotechnology (920273.BJ) trades at a P/E of 34.80x, P/B of 2.66x, P/S of 2.23x, and a dividend yield of 3.04%.
Longitudinal percentile comparison: P/E sits at the 61st percentile over the trailing 10Y window (vs. 53rd percentile over 3Y); P/B sits at the 46th percentile over the trailing 10Y window (vs. 36th percentile over 3Y); P/S sits at the 45th percentile over the trailing 10Y window (vs. 34th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 55th percentile within its industry and the 48th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.04%, ranking at the 90th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 14.4 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Hubei Yizhi Konjac Biotechnology operates in the — sector. Data refreshes weekly and is for reference only, not investment advice.
Want the full picture on whether Hubei Yizhi Konjac Biotechnology (920273.BJ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 34.80 | ||||||
| P/B (MRQ) | 2.66 | ||||||
| P/S (TTM) | 2.23 | ||||||
| Dividend Yield | 3.04% | ||||||
| Buyback + Div Yield | 3.04% |